WithdrawnNot Applicable

Progesterone for First Trimester Vaginal Bleeding

Stopped: never started

Israel0Started 2012-01

Plain-language summary

The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.

Who can participate

Age range16 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Low risk pregnancies * Intrauterine pregnancy documented sonographically * Singleton pregnancy * Known gestational age * Healthy women Exclusion Criteria: * Women after reproductive assistant techniques * Women treated with progesterone * Multiple pregnancies

What they're measuring

adverse pregnancy outcomes

Timeframe: 9 months

Trial details

NCT IDNCT01501890

SponsorSoroka University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Threatened Abortion trials